Search results for "Drug Compounding"

showing 10 items of 90 documents

Prostaglandin E(2)-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release.

2008

PGE(2), an arachidonic acid metabolite produced by various type of cells regulates a broad range of physiological activities in the endocrine, cardiovascular, gastrointestinal, and immune systems, and is involved in maintaining the local homeostasis. In the immune system, PGE(2) is mainly produced by APCs and it can suppress the Th1-mediated immune responses. The aim of this study was to develop PGE(2)-loaded biodegradable MS that prolong and sustain the in vivo release of this mediator. An o/w emulsion solvent extraction-evaporation method was chosen to prepare the MS. We determined their diameters, evaluated the in vitro release of PGE(2), using enzyme immunoassay and MS uptake by periton…

Time Factorsmedicine.medical_treatmentPhagocytosisChemistry PharmaceuticalDrug CompoundingPharmaceutical ScienceInflammationPharmacologyBiologyNitric OxideDinoprostonechemistry.chemical_compoundMiceImmune systemPhagocytosisIn vivoSepsismedicineAnimalsHumansImmunologic FactorsProstaglandin E2Particle SizeCells CulturedChemokine CCL2Tumor Necrosis Factor-alphaEndothelial CellsWaterGeneral MedicineMicrospheresDisease Models AnimalchemistryBiochemistrySolubilityDelayed-Action PreparationsMacrophages PeritonealLiberationlipids (amino acids peptides and proteins)Arachidonic acidEmulsionsmedicine.symptomInflammation MediatorsOilsBiotechnologyProstaglandin Emedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets

2001

In 1980, Lim and Sun introduced a microcapsule coated with an alginate/polylysine complex for encapsulation of pancreatic islets. Characteristic to this type of capsule is, that it consists of a plain membrane which is formed during a single procedural step. With such a simple process it is difficult to obtain instantly a membrane optimized with respect to all the properties requested for islet transplantation. To overcome these difficulties, it is recommended to build up the membrane in several consecutive steps, each optimized for a certain property. In this study, we have analysed such a multilayer microcapsule for the encapsulation of pancreatic islets. Therefore, empty and islet contai…

Transplantation HeterotopicMaterials scienceCompressive StrengthBiocompatibilityAlginatesDrug CompoundingAcrylic ResinsIslets of Langerhans TransplantationBiophysicsBiocompatible MaterialsBioengineeringPermeabilityRats Sprague-DawleyBiomaterialschemistry.chemical_compoundBiopolymersGlucuronic AcidMaterials TestingmedicineAnimalsPolyethyleneiminePolylysineParticle SizeMuscle SkeletalAcrylic resinCells CulturedHexuronic AcidsPancreatic isletsBiomaterialCapsuleProstheses and ImplantsFibrosisMicrospheresRatsQuaternary Ammonium CompoundsTransplantationmedicine.anatomical_structureMembranechemistryRats Inbred LewMechanics of MaterialsCarboxymethylcellulose Sodiumvisual_artPolylysineCeramics and Compositesvisual_art.visual_art_mediumFemalePolyethylenesBiomedical engineeringBiomaterials
researchProduct

Organic solvent vapor effects on phase transition of α and β tegafur upon grinding with solvent additives.

2012

Abstract Solvent effects on α tegafur (5-fluoro-1-(tetrahydro-2-furyl)uracil) phase transition to β tegafur during grinding with solvent additive, as well as phase transition in samples exposed to 95% relative solvent vapor pressure has been studied in this research. Samples containing 0.5% and 0.1% of β tegafur in α and β tegafur mixture, as well as samples of pure α tegafur were ground with different solvent additives, and conversion degrees depending on the solvent were determined using PXRD method. Samples with α and β tegafur weight fraction of 1:1 were exposed to 95% relative solvent vapor pressure, and phase transition rates were determined. Solubility of α tegafur, solvent sorption …

Vapor PressureChemistryDrug CompoundingInorganic chemistryPharmaceutical ScienceSorptionTegafurPhase TransitionSolventPolymorphism (materials science)IsomerismSolubilityX-Ray DiffractionDesorptionAlcoholsmedicineSolventsThermodynamicsAdsorptionSolubilitySolvent effectsVolatilizationMass fractionmedicine.drugTegafurInternational journal of pharmaceutics
researchProduct

Vascular Endothelial Growth Factor-Releasing Microspheres Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers In…

2020

Pancreatic islet transplantation is a promising advanced therapy that has been used to treat patients suffering from diabetes type 1. Traditionally, pancreatic islets are infused via the portal vein, which is subsequently intended to engraft in the liver. Severe immunosuppressive treatments are necessary, however, to prevent rejection of the transplanted islets. Novel approaches therefore have focused on encapsulation of the islets in biomaterial implants which can protect the islets and offer an organ-like environment. Vascularization of the device’s surface is a prerequisite for the survival and proper func- tioning of transplanted pancreatic islets. We are pursuing a prevascularization s…

Vascular Endothelial Growth Factor APDMS implantsTime FactorsDrug CompoundingPolyestersPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyPolyethylene Glycols03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePEG ratioHyaluronic acidHuman Umbilical Vein Endothelial CellsmedicineHumansDimethylpolysiloxanesHyaluronic Aciddiabetes type 1Cells CulturedCell Proliferationmultiblock copolymersDrug ImplantsDrug CarriersPancreatic isletsartificial pancreasBiomaterial021001 nanoscience & nanotechnologyControlled releaseVEGFMicrospheres3. Good healthVascular endothelial growth factorDrug Liberationmedicine.anatomical_structurechemistryPrinting Three-DimensionalAngiogenesis Inducing AgentsPancreatic islet transplantationcontrolled release PDMS implants VEGF multiblock copolymers diabetes type 1 artificial pancreas0210 nano-technologycontrolled releaseCaprolactoneBiomedical engineering
researchProduct

Photocrosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery.

2007

Abstract The aim of this study was to prepare and characterize novel hydrogels with polysaccharide–polyaminoacid structure, able to undergo an enzymatic hydrolysis in the colon and potentially useful for treating inflammatory bowel diseases (IBD). Starting materials were methacrylated dextran (DEX-MA) and methacrylated α,β-poly(N-2-hydroxyethyl)- dl -aspartamide (PHM). These polymers were photocrosslinked by exposure of their aqueous solutions at 313 nm without photoinitiators. Different samples, shaped as microparticles, were obtained as a function of polymer concentration and irradiation time. FT-IR analysis confirmed the occurrence of a co-crosslinking between DEX-MA and PHM in all exper…

alpha; beta-poly(n-2-hydroxyethyl)-dl-aspartamide; biodegradable hydrogels; colon drug delivery; dextran; photocrosslinking; α; β-poly(n-2-hydroxyethyl)-dl-aspartamidealphaCell SurvivalColonPhotochemistryDrug CompoundingαPharmaceutical ScienceDosage formchemistry.chemical_compoundDrug StabilityEnzymatic hydrolysismedicineCell AdhesionOrganic chemistryHumansParticle Sizeβ-poly(n-2-hydroxyethyl)-dl-aspartamideDrug CarriersChromatographyDextranaseAqueous solutionChemistryHydrolysisbiodegradable hydrogelstechnology industry and agriculturecolon drug deliveryBeclomethasoneMucinsDextransHydrogelsHydrogen-Ion ConcentrationDextranCross-Linking Reagentsbeta-poly(n-2-hydroxyethyl)-dl-aspartamidedextranDrug deliverySelf-healing hydrogelsMethacrylatesSwellingmedicine.symptomphotocrosslinkingCaco-2 CellsPeptidesJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system

2018

The automated aseptic preparation of ready-to-administer antineoplastic drug solutions with robotic systems reduces the risk of occupational exposure. However, the surfaces in the preparation area of the robot are to be cleaned by wiping with an appropriate cleaning solution. The aim of the study was to evaluate the cleaning efficacy of four cleaning solutions on four surface materials installed in the APOTECAchemo robot. Predefined amounts of cisplatin (Cis), 5-fluorouracil (5-FU), and cyclophosphamide (CP) were intentionally spread on test plates made of stainless steel, aluminium, polyoxymethylene, and polycarbonate just as installed in the robotic system APOTECAchemo. After drying, the …

business.industryDrug CompoundingAntineoplastic drugDetergentsPublic Health Environmental and Occupational HealthAntineoplastic AgentsRoboticsHuman decontaminationPharmacologyRobotic systemsCompoundingAntineoplastic DrugsMedicineFluorouracilAseptic processingOccupational exposureCisplatinPharmacy Service HospitalbusinessCyclophosphamideDecontaminationJournal of Occupational and Environmental Hygiene
researchProduct

Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo users.

2016

Purpose The development of recommendations for advancing automated i.v. medication compounding is described. Summary Managing the shift from manual to robotic compounding of i.v. therapies requires an awareness of how automation affects practice and how to best implement robotics into current practice. An international panel of pharmacy professionals, researchers, and technology leaders with experience in i.v. robotics collaborated during a two-day meeting in August 2014 to define a general set of principles to broaden the understanding of the fundamental elements of robotic compounding worldwide. Participants were divided into four working groups (technology and safety; drugs and products;…

media_common.quotation_subjectDrug CompoundingPharmacy030226 pharmacology & pharmacy03 medical and health sciencesAutomation0302 clinical medicineNursingSurveys and QuestionnairesMedicineHumansQuality (business)Set (psychology)media_commonPharmacologyDrug compoundingMedical educationbusiness.industryHealth PolicyInternational communityRoboticsCompoundingCurrent practice030220 oncology & carcinogenesisPractice Guidelines as TopicAdministration IntravenousWorking groupbusinessPharmacy Service HospitalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
researchProduct

Compounded preparations in dermatology – analysis of prescribing habits in everyday clinical practice in Germany

2020

Background Compounded preparations (CPs) are an indispensable addition to approved, commercially available drugs (CADs), especially for topical therapy. In Germany, about eight million CPs are prescribed within the statutory health insurance system each year, 50 % thereof by dermatologists. Methods We analyzed prescribing habits based on a questionnaire sent out to 186 office-based dermatologists and 1,491 pharmacies in the federal states of Rhineland-Palatinate and Saarland. The goal was to improve patient care by collecting and categorizing data in terms of prescription practice and associated challenges in interdisciplinary cooperation. Results Overall, 351 pharmacists (23.5 %) and 53 de…

medicine.medical_specialtyDrug CompoundingMEDLINEContext (language use)PharmacyDermatologyPharmacistsSkin Diseases030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineContinuing medical educationGermanySurveys and QuestionnairesHumansMedicinePractice Patterns Physicians'Medical prescriptionPharmaciesbusiness.industryCompounded preparationsTopical medicationClinical PracticeCross-Sectional StudiesFamily medicineDermatologic AgentsbusinessDermatologistsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension deliver…

2018

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs), are central to the maintenance treatment of patients with COPD. Clinical studies have demonstrated that combined LAMA + LABA therapies improve efficacy while retaining a safety profile similar to LAMA or LABA alone. This has led to the development of several LAMA/LABA fixed-dose combination (FDC) therapies, which provide patients with the convenience of two active compounds in a single inhaler. GFF MDI (Bevespi Aerosphere®) is an FDC of glycopyrrolate/formote…

medicine.medical_specialtymedicine.drug_classDrug CompoundingFixed-dose combinationMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumans030212 general & internal medicineIntensive care medicineAdrenergic beta-2 Receptor AgonistsGlycopyrrolateCOPDbiologybusiness.industryInhalerGeneral MedicineLamamedicine.diseasebiology.organism_classificationGlycopyrrolateMetered-dose inhalerBronchodilator AgentsDrug CombinationsTreatment Outcome030228 respiratory systemFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Encapsulation of Vitamins A and E as Spray-Dried Additives for the Feed Industry

2020

Encapsulated fat-soluble powders containing vitamin A (VA) and E (VE) were prepared as a feasible additive for extruded feed products. The effect of the encapsulating agents (Capsul-CAP&reg

medicine.medical_treatmentPharmaceutical Science02 engineering and technologyAnalytical Chemistrychemistry.chemical_compoundSpectroscopy Fourier Transform InfraredDrug DiscoveryVitamin E03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesVitamin ACalorimetry Differential ScanningTemperatureSpray Drying04 agricultural and veterinary sciences021001 nanoscience & nanotechnologyMaltodextrin040401 food science02.- Poner fin al hambre conseguir la seguridad alimentaria y una mejor nutrición y promover la agricultura sostenibleChemistry (miscellaneous)Spray dryingThermogravimetryMAQUINAS Y MOTORES TERMICOSMolecular MedicineEmulsionsExtrusionPowders0210 nano-technologyOxidation-ReductionPorosityMaterials scienceNanoemulsionsDrug CompoundingSodiumChemical structureSpray-dryingchemistry.chemical_elementArticle14.- Conservar y utilizar de forma sostenible los océanos mares y recursos marinos para lograr el desarrollo sosteniblelcsh:QD241-4410404 agricultural biotechnologylcsh:Organic chemistrymedicineThermal stabilityParticle SizePhysical and Theoretical ChemistryPorosityVitamin EOrganic ChemistryHumidityChemical engineeringchemistryDietary SupplementsNanoparticlesEncapsulationMolecules
researchProduct